Max Healthcare Q4 Results: Max Healthcare Institute Ltd today (May 16, 2023) announced its results for the January-March quarter, clocking a rise of 102.80 per cent in its consolidated Year on Year profit, from Rs 123.73 crore to Rs 250.92 crore.  

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

The company consolidated YoY income also rose 30.22 per cent, from Rs 963.51 crore to Rs 1254.73 crore. 

Max Healthcare's revenue from operations was up 29.60 per cent, from Rs 937.09 crore in Q4 FY22 to Rs 1214.51 crore in the quarter under review.  

Dividend of 10 per cent

The board has also recommended a dividend of Rs 1 per equity share (10 per cent of face value of Rs 10 each) for the financial year 2022-23.  

Max Healthcare share price fell 1.87 per cent from opening. The share is down to Rs 510.15 at present. 

The company's network operating EBITDA jumped 44 per cent to a new high of Rs 437 crore and 4 per cent Quarter on Quarter.

The company in its filing said that the cash from operations was Rs 425 crore in Q4 FY23, while its net cash as on March 31, 2023 stood at Rs 733 crore.

Max Healthcare reported a growth of 18 per cent in its gross revenue in FY23, which is now at Rs 6,234 crore. The company's network operating EBITDA in FY23 was Rs 1,636 crore, an increase of 25 per cent.